Latest Articles
Ovarian Cancer Risk Rises Soon After IBS Diagnosis - Medscape
Ovarian Cancer Risk Rises Soon After IBS Diagnosis Medscape
Published: July 28, 2025, 7:58 a.m.
Scots dad takes on fundraising skydive after teen son diagnosed with brain cancer - Daily Record
Scots dad takes on fundraising skydive after teen son diagnosed with brain cancer Daily Record
Published: July 27, 2025, 3:30 a.m.
This Silent Cancer Is Surging—And Certain Women Face the Greatest Risk - NewsBreak: Local News & Alerts
This Silent Cancer Is Surging—And Certain Women Face the Greatest Risk NewsBreak: Local News & Alerts
Published: July 25, 2025, 4:58 p.m.
GSK’s Phase 2 Trial on Dostarlimab for Endometrial Cancer: A Market Game Changer? - TipRanks
GSK’s Phase 2 Trial on Dostarlimab for Endometrial Cancer: A Market Game Changer? TipRanks
Published: July 25, 2025, 4:19 p.m.
This Silent Cancer Is Surging—And Certain Women Face the Greatest Risk - bestlifeonline.com
This Silent Cancer Is Surging—And Certain Women Face the Greatest Risk bestlifeonline.com
Published: July 25, 2025, 3:59 p.m.
James Whale reveals he’s struggling to breathe and talk in terminal cancer update - The Independent
James Whale reveals he’s struggling to breathe and talk in terminal cancer update The Independent
Published: July 25, 2025, 11:26 a.m.
T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer - Journal of Translational Medicine
T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer Journal of Translational Medicine
Published: July 24, 2025, 9:25 p.m.
Research uses AI to find pathologic and genetic basis for worse outcome of endometrial cancer in Black women - Medical Xpress
Research uses AI to find pathologic and genetic basis for worse outcome of endometrial cancer in Black women Medical Xpress
Published: July 24, 2025, 2:29 p.m.
RUBY Trial: Real-World Safety, Efficacy Analysis, and Quality of Life Considerations in Endometrial Cancer - OncLive
RUBY Trial: Real-World Safety, Efficacy Analysis, and Quality of Life Considerations in Endometrial Cancer OncLive
Published: July 24, 2025, 2:03 p.m.
SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer - OncLive
SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer OncLive
Published: July 24, 2025, 1:49 p.m.
Link copied to clipboard!